real-time PCR;
M184V;
minor populations;
drug resistance;
HIV;
D O I:
10.1016/j.jviromet.2005.03.007
中图分类号:
Q5 [生物化学];
学科分类号:
071010 [生物化学与分子生物学];
081704 [应用化学];
摘要:
A selective real-time PCR (SPCR) method was developed and evaluated for discrimination of resistance mutations in minor human immunodeficiency virus type 1 (HIV-1) populations, using the M184 mutation site as a model system due to its high clinical importance and the low genetic barrier to its development. The method enabled detection of minor viral populations down to 0.1%, and the relative proportions of different quasispecies could be easily displayed using cycle threshold (C-t) values. An excellent concordance was found when the assay was compared with direct sequencing and cloning results. The impact of mismatch between virus and primer/probe sequences was evaluated, showing that 3' end mutations in the selective downstream primers were very disruptive and that 5' end polymorphisms in the probe area were directly fatal, while mutations in the middle or the 3' end of the probe were less disruptive. These effects were compensated by introducing wobble bases to accommodate the mutations. This sensitive and reliable point-mutation assay, analyzing M184I/V and other important mutations, will be fruitful in gaining new scientific knowledge about the kinetics of resistance mutations in minor viral populations of HIV-1 infected patients at failure of antiretroviral therapy. (c) 2005 Elsevier B.V. All rights reserved.
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Harrigan, PR
;
Stone, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Stone, C
;
Griffin, P
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Griffin, P
;
Nájera, I
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Nájera, I
;
Bloor, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Bloor, S
;
Kemp, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Kemp, S
;
Tisdale, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Tisdale, M
;
Larder, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Harrigan, PR
;
Stone, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Stone, C
;
Griffin, P
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Griffin, P
;
Nájera, I
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Nájera, I
;
Bloor, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Bloor, S
;
Kemp, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Kemp, S
;
Tisdale, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England
Tisdale, M
;
Larder, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, EnglandGlaxo Wellcome Res & Dev Ltd, Clin Virol & Surrogates Unit, Stevenage SG1 2NY, Herts, England